FACULTY
The Importance of Community Pharmacist Intervention in Optimizing HIV Patient Outcomes
Paper Symposium
Activity Date: May 2006  — Activity Info: Volume 3, (2)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

Full Disclosure Policy Affecting CE Activities:
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:

PROGRAM DIRECTOR

Camille Thornton, PharmD, BCPS
Clinical Pharmacist, HIV-AIDS
Assistant Professor
University of Tennessee
Memphis, Tennessee
Dr Thornton reports having no financial or advisory relationshipswith corporate organizations related to this activity.


PARTICIPATING FACULTY

Billy R. Brown, PharmD
Clinical Assistant Professor
University of Mississippi School of Pharmacy
Jackson, Mississippi
Dr Brown reports receiving grants/research support from Bristol-Myers Squibb Company, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Pfizer Inc, and Roche; and serving as a consultant for Bristol-Myers Squibb Company, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Pfizer Inc, and Roche.

Jean C. Lee, PharmD, BCPS
Clinical Pharmacist-HIV/AIDS
McAuley Health Center
Saint Mary's Health Care
Grand Rapids, Michigan
Dr Lee reports serving on the speaker's bureau for Bristol-Myers Squibb Company, Boehringer Ingelheim, Gilead, GlaxoSmithKline, and Roche.

Frank Romanelli, PharmD, BCPS
Associate Professor of Pharmacy
College of Pharmacy and College of Health Sciences
University of Kentucky
Lexington, Kentucky
• Dr Romanelli reports having no financial or advisory relationships with corporate organizations related to this activity.

Notice: In accordance with the ACPE Criteria for Quality, the audience is advised that articles in this continuing pharmaceutical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices.

Dr Lee—alendronate, atazanavir, metformin, recombinant growth hormone, rosuvastatin, testosterone, and thiazolidinediones.

All other faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.

University of Tennessee Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. University of Tennessee Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?